Correlation Between Mineralys Therapeutics, and Lexaria Bioscience
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Lexaria Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Lexaria Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Lexaria Bioscience Corp, you can compare the effects of market volatilities on Mineralys Therapeutics, and Lexaria Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Lexaria Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Lexaria Bioscience.
Diversification Opportunities for Mineralys Therapeutics, and Lexaria Bioscience
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and Lexaria is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Lexaria Bioscience Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lexaria Bioscience Corp and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Lexaria Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lexaria Bioscience Corp has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Lexaria Bioscience go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Lexaria Bioscience
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Lexaria Bioscience. But the stock apears to be less risky and, when comparing its historical volatility, Mineralys Therapeutics, Common is 1.69 times less risky than Lexaria Bioscience. The stock trades about -0.01 of its potential returns per unit of risk. The Lexaria Bioscience Corp is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 70.00 in Lexaria Bioscience Corp on September 1, 2024 and sell it today you would earn a total of 10.00 from holding Lexaria Bioscience Corp or generate 14.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Lexaria Bioscience Corp
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Lexaria Bioscience Corp |
Mineralys Therapeutics, and Lexaria Bioscience Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Lexaria Bioscience
The main advantage of trading using opposite Mineralys Therapeutics, and Lexaria Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Lexaria Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexaria Bioscience will offset losses from the drop in Lexaria Bioscience's long position.| Mineralys Therapeutics, vs. Tff Pharmaceuticals | Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. Inhibrx | Mineralys Therapeutics, vs. Enliven Therapeutics |
| Lexaria Bioscience vs. Lexaria Bioscience Corp | Lexaria Bioscience vs. Lixte Biotechnology Holdings | Lexaria Bioscience vs. GeoVax Labs | Lexaria Bioscience vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |